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http:WHAT THIS PAPER ADDS
Unique to the literature, this study demonstrates that the recommended treatment for intermittent claudication
(IC) may be detrimental to long-term health outcomes. Supervised treadmill-based exercise training requires
patients to walk beyond the onset of claudication pain with a view that physiological adaptations to the relative
ischaemia induced by such training lead to improvements in walking performance. It seems, however, that such
repeated ischaemiaereperfusion insults can also lead to a catabolic muscle wasting state, potentially through
activation of the calpain system. Findings from this study challenge whether treadmill-based exercise training
should remain the recommended treatment for patients with IC.Objectives: Supervised exercise training (SET) is recommended for patients with intermittent claudication (IC).
The optimal exercise programme has not been identiﬁed, and the potential adverse effects of exercise on these
patients warrant consideration. Calpain proteases have been linked with tissue atrophy following ischaemiae
reperfusion injury. High calpain activity may therefore cause muscle wasting in claudicants undergoing SET, and
skeletal muscle mass (SMM) is integral to healthy ageing. This study assesses the impact of (1) treadmill-based
SET alone; and (2) treadmill-based SET combined with resistance training on pain-free walking distance (PFWD),
SMM, and calpain activity.
Methods: Thirty-ﬁve patients with IC were randomised to 12 weeks of treadmill only SET (group A), or combined
treadmill and lower-limb resistance SET (group B). PFWD via a 6-minute walking test, SMM via dual energy X-ray
absorptiometry, and calpain activity via biopsies of gastrocnemius muscles were analysed.
Results: Intention-to-treat analyses revealed PFWD improved within group A (160 m to 204 m, p ¼ .03), but not
group B (181 m to 188 m, p ¼ .82). There was no between group difference (p ¼ .42). Calpain activity increased
within group A (1.62  105 ﬂuorescent units [FU] to 2.21  105 FU, p ¼ .05), but not group B. There was no
between group difference (p ¼ .09). SMM decreased within group A (250 g, p ¼ .11) and increased in group B
(210 g, p ¼ .38) (p ¼ .10 between groups). Similar trends were evident for per protocol analyses, but,
additionally, change in SMM was signiﬁcantly different between groups (p ¼ .04).
Conclusions: Neither exercise regimen was superior in terms of walking performance. Further work is required to
investigate the impact of the calpain system on SMM in claudicants undertaking SET.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Regular physical activity can improve symptomatology and
prognosis in those with chronic disease.1 In addition to the
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//dx.doi.org/10.1016/j.ejvs.2013.12.021conditioning, consensus guidelines recommend that su-
pervised exercise training (SET) should be made available
as a treatment for adults with intermittent claudication
(IC) on the basis of high-quality evidence demonstrating
improved walking performance following SET of sufﬁcient
intensity to induce moderate claudication pain.2 Despite
these recommendations, literature is scant in relation to
the long-term health outcomes of patients with IC un-
dertaking SET.
Adverse consequences of SET are possible and warrant
investigation. Ischaemiaereperfusion injury (IRI) is
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microvascular permeability.3 In IC, low-grade IRI occurs after
each bout of exercise-induced pain.4 This correlates with an
increase in pro-inﬂammatory cytokines and may be
responsible for the acute impairment in endothelial func-
tion observed after exercise in these patients.5
The calpain system is a family of calcium dependent
proteases and their endogenous inhibitor calpastatin.6
Skeletal muscle expresses two ubiquitous calpains (u-cal-
pain and m-calpain) and a muscle-speciﬁc calpain (calpain-
3).6 After a stimulus such as exercise, the intracellular
calcium concentration increases, leading to calpain acti-
vation.6 Activated, calpains can cause morphological
damage to skeletal muscle.6 Loss of calcium homeostasis
during IRI leads to unregulated activation of calcium-
dependent enzymes, including the calpain system. This
precipitates an extensive proteolytic response leading to
cell death.7
Evidence from animal models supports a role for
calpain-induced muscle atrophy in individuals with pe-
ripheral arterial disease (PAD). A rat model of chronic
ischaemia demonstrated ischaemia-induced muscle atro-
phy to be more severe in exercise-trained rats than un-
trained rats, suggesting that under impaired vascular
conditions, exercise training may not be beneﬁcial in
maintaining muscle mass.8 In humans with PAD, lower
extremity ischaemia can have a detrimental effect on calf
skeletal muscle area when compared to age-matched pa-
tients with normal perfusion status.9 The impact of exer-
cise on muscle mass in these patients is yet to be
investigated.
The importance of muscle mass in optimising health
outcomes is established. Preservation of muscle mass is an
important determinant of ability to perform activities of
daily living, quality of life, and survival.10 Resistance training
as an alternative form of SET in patients with IC has pre-
viously demonstrated improvements in strength and
walking performance comparable to treadmill-based SET.11
Whether a resistance training SET that preserves skeletal
muscle mass (SMM) and limits exposure to IRI translates to
an improvement in long-term health outcomes superior to
treadmill-based SET is unknown.
The purpose of this study was therefore to investigate
the impact of treadmill-based SET alone or in combination
with lower limb resistance training on the primary outcome
of pain-free walking distance (PFWD) and secondary out-
comes, 6-minute walking distance (6MWD), SMM, and
calpain activity.
MATERIALS AND METHODS
Sampling
This study was a single-centre randomised controlled trial in
which patients presenting to the Southern Adelaide Health
Service Vascular Surgery Department between January
2011 and July 2012 were screened for eligibility. The study
was approved by the regional ethics committee. All par-
ticipants provided written informed consent.Inclusion and exclusion criteria
Patients with a clinical history consistent with IC, ankle
brachial pressure index (ABPI) <0.9 and radiographic evi-
dence of infra-inguinal disease in the absence of aorto-iliac
disease were eligible for inclusion. Patients were excluded if
they (1) had a diagnosis of critical limb ischaemia, (2) had
recently (<12 months) undergone peripheral vascular
intervention (open surgery or endovascular), or (3) suffered
from pre-existing cardio-respiratory morbidities limiting
exercise capacity.Demographics and medical history
Comorbidities, current medications, and smoking status
were recorded as part of baseline clinical assessment. De-
mographic information, including gender and age, was also
collected.Randomisation
Participants were randomised to either group A (12-week
treadmill-based SET alone) or group B (12-week treadmill-
based SET in combination with lower limb resistance
training). Randomisation was performed with a computer-
based random number generator using a 1:1 allocation ra-
tio for block sizes which represented the number of par-
ticipants recruited within each 3-monthly interval.Sample size
For the primary outcome of PFWD, sample size was esti-
mated based on the baseline PFWD reported by Gardner
et al. (172 m)12 and the mean improvement in PFWD
following SET suggested by a recent Cochrane review
(82.2 m)13dapproximately a 30% improvement. Data from
McGuigan et al.14 suggested that improvement in PFWD
following a 24-week resistance-based SET was 158%, an
additive effect of 128% from resistance-based SET alone.
Given that our intervention was 12 weeks long, we halved
the expected effect size to 64%, utilised a conservative SD
of 75 m (a ¼ 0.05, b ¼ 0.8), and calculated the total sample
size required to be n ¼ 28 (14 per group).SET
The SET ran over 12 weeks and consisted of two 60-minute
sessions per week supervised by a senior physiotherapist.
Prior to the commencement of SET, patients were advised
to maintain their baseline level of daily activity for the 12
weeks.
Group A: treadmill-based SET. Participants were advised to
walk until claudication pain became unbearable. They then
rested until pain resolved and repeated the cycle for the
duration of the session. Initial treadmill speed was deter-
mined by distance covered in the baseline 6-minute walking
test. If the participant did not experience symptoms within
10 minutes of walking, the pace or gradient of walking was
increased by 10%.
Figure 1. CONSORT diagram outlining the ﬂow of participants through the study. Note. ABPI ¼ ankle brachial pressure index;
SET ¼ supervised exercise training.
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educated to undertake three sets of 8e12 repetitions of
hamstring curls, seated calf press, leg press, knee extension,
and hip abduction/adduction. For each exercise, partici-
pants commenced at the minimum level of resistance.
Resistance increased by 5% each time participants achieved
12 repetitions/set Following completion of resistance ex-
ercises, participants were asked to walk on the treadmill
until the onset of claudication pain only. They then rested
until the pain resolved before recommencing resistance
exercises. This cycle was repeated for the duration of each
session. Initial walking speed and graded increases were
determined as described for group A.
Outcome assessments
All measurements were performed within 1 week prior to
the commencement of SET and 1 week after completion of
SET. Assessors were blinded to allocation.
Six-minute walk test. A standardised protocol was followed.
Participants rested for 30 minutes before walking, self-paced along an indoor, ﬂat, straight walkway marked at
regular intervals. PFWD was recorded as the distance at
which participants ﬁrst reported claudication pain. The
distance covered over the course of the 6 minutes was
recorded as the 6MWD.
Muscle biopsy technique. Ultrasound-guided needle biopsy
of symptomatic medial gastrocnemius muscle was per-
formed using a disposable core biopsy instrument. In cases
where both legs were symptomatic, the leg with the lowest
resting ABPI was chosen. Muscle samples were immediately
snap frozen in liquid nitrogen and stored at 80.
Calpain and calpastatin activity. For each sample, skeletal
muscle extract (containing 50 mg protein) was added to a
microtitre plate well and analysis of m-calpain and calpas-
tatin activity was undertaken according to a previously
validated technique.15 All samples were assayed in dupli-
cate. Calpain activity was expressed as ﬂuorescent units
(FU) and calpastatin activity as % inhibition of calpain
activity.
Table 1. Baseline characteristics between participants in the
treadmill-only supervised exercise training (SET) and the
treadmill and resistance exercise SET. Data presented as n (%)
unless otherwise stated.
Demographics and
medical history
Treadmill only
(n ¼ 18)
Treadmill and
resistance
training
(n ¼ 17)
p-value
Mean (SD) age, y 73.4 (9.1) 69.4 (9.6) 0.22
Male:female ratio 12:5 13:4 0.52
Current/ex-smoker 13 (72) 13 (76) 0.77
Mean (SD) body
mass index, kg/m2
27.0 (4.3) 29.0 (5.6) 0.39
Ischaemic heart 6 (33) 8 (47) 0.41
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estimated using dual energy X-ray absorptiometry (DEXA)
with the automated reporting bone densitometry software.
Appendicular lean soft tissue mass from DEXA was used to
determine SMM according to an established equation.16 For
the calculation and analysis of SMM in symptomatic and
asymptomatic legs, given that some participants suffered
unilateral claudication and others bilateral claudication,
data from each leg were considered as separate entities.
Adherence to SET. Attendance at each exercise session was
recorded and satisfactory completion of the SET was
determined to be attendance at >80% of sessions.disease
Dyslipidaemia 16 (89) 16 (94) 0.58
Hypertension 14 (78) 15 (88) 0.41
Diabetes
mellitus
6 (33) 10 (59) 0.13Data analysis
The primary analysis was undertaken on an intention-to-
treat (ITT) basis with those lost to follow-up at 12 weeks
having their baseline measure carried forward. For per-
protocol analysis, all participants achieving <80% adher-
ence to the allocated SET and those that were lost to follow-
up were excluded from the analysis. SPSS v. 19 was used to
perform statistical analyses. Continuous data are reported
as mean (SD) and categorical data as n (%). Differences
within groups for continuous data were tested using paired
samples t tests and change from baseline to 12 weeks be-
tween groups using independent samples t tests. Differ-
ences between groups for categorical data were tested
using chi-square test. Two-way analysis of covariance was
applied to the primary outcome (PFWD) with adjustment
for age and gender, and testing for an interaction effect
between group and gender. Statistical signiﬁcance of
p < .05 was assumed.RESULTS
Thirty-ﬁve of 46 patients with IC meeting the inclusion
criteria agreed to participate in the study, 76% consent rate.
Fig. 1 illustrates the ﬂow of participants from enrolment
into the study to follow-up at 12 weeks on completion of
the allocated SET.
At baseline there was no signiﬁcant difference between
groups in lowest resting ABPI; mean 0.71 (SD 0.23) and mean
0.72 (SD 0.15) for group A and group B respectively (p¼ .97).
On commencement of the SET, all participants in each group
were on antiplatelet and lipid-lowering agents, while 15
(83%) and 15 (88%) were on anti-hypertensive agents in
group A and group B respectively (p¼ .68). Table 1 highlights
baseline demographic characteristics and medical history of
participants according to group allocation. There were no
statistically signiﬁcant differences between groups identiﬁed
according to allocation for age, gender, body mass index,
smoking status, or medical history.
Table 2 highlights the change in the outcome measures
from baseline to 12 weeks according to allocation, for both
ITT and per-protocol analyses. There were no statistically
signiﬁcant differences observed between groups at baseline.
PFWD increased signiﬁcantly between baseline and 12
weeks for group A. A small increase was achieved betweenbaseline and 12 weeks for group B; however, this did not
achieve statistical signiﬁcance and there was no between
group difference for the increase observed in PFWD. After
adjustment for age and gender there remained no signiﬁ-
cant difference between the two groups (group: F
[1,27] ¼ 1.832, p ¼ .187; gender: F[1,27] ¼ .144, p ¼ .707;
age: F[1,27] ¼ .671, p ¼ .420) nor was there any interaction
between group and gender (F[1,27] ¼ 1.619, p ¼ .214).
6MWD improved in both groups between baseline and
12 weeks; however, this only achieved statistical signiﬁ-
cance for those participants allocated to group A. There
were no between group differences identiﬁed.
Calpain activity increased in group A and decreased in
group B between baseline and 12 weeks for ITT analyses,
reaching statistical signiﬁcance within group A only. The
between group comparison did not achieve statistical sig-
niﬁcance and when per-protocol analyses were performed,
the within and between group differences were similar in
magnitude and statistical signiﬁcance. Calpastatin activity
did not achieve statistical signiﬁcance within or between
groups. Coefﬁcient of variance was 5.8% and 39.8% for
calpain and calpastatin activity respectively.
SMM demonstrated a non-signiﬁcant decrease between
baseline and 12 weeks for those allocated to group A. A
non-signiﬁcant increase in SMM was observed between
baseline and 12 weeks for those allocated to group B. On
per-protocol analysis statistical signiﬁcance was achieved
for between group differences.
For the symptomatic leg, SMM decreased non-
signiﬁcantly for those allocated to group A. In contrast,
SMM of the symptomatic leg for those allocated to group B
increased in both ITT and per-protocol analyses, and while
this within group change from baseline to 12 weeks did not
reach statistical signiﬁcance on ITT analysis, it was statisti-
cally signiﬁcant on per-protocol analysis (p ¼ .04). These
results translated into a borderline statistically signiﬁcant
difference between groups on ITT analysis (p ¼ .05) and a
clear signiﬁcance on per-protocol analysis (p ¼ .02).
Table 2. Comparison of baseline, 12-week, and absolute change for outcomes between participants in the treadmill-only supervised
exercise training and the treadmill and resistance exercise training. Data presented as mean (SD) unless otherwise stated. For
intention-to-treat (ITT) purposes n-values vary according to whether last outcome carried forward was used or where no baseline
measure was available the follow-up value remained missing.
Outcome Treadmill only Treadmill and resistance training Between
group pBaseline 12 weeks Change p Baseline 12-weeks Change p
ITTa
Pain-free walking distance, m 160 (84) 204 (97) 44 (80) .03 181 (90) 188 (109) 7 (135) .82 .42
6-minute walking distance, m 354 (99) 386 (85) 32 (47) .01 368 (69) 419 (168) 51 (165) .21 .67
Calpain activity, FU (105) 1.62 (0.95) 2.21 (1.26) 0.59 (1.24) .05 1.67 (0.90) 1.45 (1.39) 0.22 (1.43) .55 .09
Calpastatin activity, FU (106) 2.74 (1.05) 3.13 (1.11) 0.39 (1.45) .27 2.93 (1.00) 2.68 (0.92) 0.25 (1.39) .50 .21
SMM,b kg 23.72 (6.77) 23.47 (6.62) 0.25 (0.55) .11 25.43 (5.42) 25.64 (5.52) 0.21 (0.81) .38 .10
Symptomatic leg SMM,c kg 7.90 (2.16) 7.80 (2.10) 0.10 (0.28) .10 8.38 (1.65) 8.52 (1.80) 0.14 (0.47) .19 .05
Asymptomatic leg SMM,d kg 7.62 (1.65) 7.81 (1.92) 0.19 (0.28) .21 7.86 (1.40) 7.96 (1.31) 0.10 (0.20) .19 .58
Per protocol
Pain-free walking distance,e m 170 (82) 221 (97) 50 (78) .03 170 (90) 188 (127) 18 (147) .67 .59
6-minute walking distance,e m 371 (94) 409 (70) 38 (49) .01 358 (68) 439 (188) 81 (189) .16 .47
Calpain activity,f FU (105) 1.35 (0.59) 2.11 (1.25) 0.76 (1.37) .05 1.60 (0.99) 1.45 (1.50) 0.15 (1.55) .75 .13
Calpastatin activity,f FU (106) 2.64 (1.10) 3.18 (1.19) 0.54 (1.69) .28 2.83 (1.02) 2.62 (0.95) 0.21 (1.53) .65 .27
SMM,g kg 22.84 (6.93) 22.64 (6.74) 0.20 (0.59) .28 25.24 (5.91) 25.64 (6.05) 0.40 (0.70) .09 .04
Symptomatic leg SMM,h kg 7.96 (2.29) 7.88 (2.21) 0.08 (0.28) .271 8.35 (1.81) 8.59 (1.97) 0.24 (0.40) .04 .02
Asymptomatic leg SMM,i kg 8.10 (1.48) 8.40 (1.64) 0.30 (0.16) .03 7.70 (1.44) 7.85 (1.38) 0.15 (0.16) .05 .19
Note. FU ¼ ﬂuorescent unit; SMM ¼ skeletal muscle mass.
a Five and three participants in groups A and B, respectively, did not complete the study. Of these, three and two, respectively, returned for
follow-up assessment and hence contributed data for ITT purposes. Two and one, respectively, did not return for a follow-up and hence had
their baseline data carried forward to enable ITT analysis.
b n ¼ 14 in group A and n ¼ 13 in group B.
c n ¼ 23 in group A and n ¼ 18 in group B.
d n ¼ 5 in group A and n ¼ 8 in group B.
e n ¼ 15 in group A and n ¼ 12 in group B.
f n ¼ 14 in group A and n ¼ 12 in group B.
g n ¼ 11 in group A and n ¼ 11 in group B.
h n ¼ 19 in group A and n ¼ 16 in group B.
i n ¼ 4 in group A and n ¼ 7 in group B.
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from baseline to 12 weeks within groups, which achieved
statistical signiﬁcance on per-protocol analysis (p ¼ .03 and
p ¼ .05 for group A and group B respectively). There was no
between group difference detected in either ITT or per-
protocol analyses.
DISCUSSION
The impact of different modalities of SET on body compo-
sition and the role of calpain proteases in augmenting such
an impact has not previously been investigated in patients
with IC. Furthermore, the quest for the most effective ex-
ercise regimen to maximise improvements in walking per-
formance in these patients is ongoing.
This study has identiﬁed that conventional SET recom-
mended to those with IC can increase calpain proteolytic
activity with a relative reduction of SMM, which may be
detrimental to long-term health outcomes. While this study
was unable to conﬁrm that a combined treadmill and
resistance training programme can achieve the equivalent
gains in walking performance as a programme of treadmill
training alone, it does highlight the need for greater scrutiny
of exercise programmes in these patients where delay in
disease progression is critical.Treadmill-based SET until moderate claudication pain is
recommended for IC;2 however, the most effective exercise
regimen remains unclear. In our study, exercise to the
extreme of claudication pain was prescribed in an attempt
to maximise the beneﬁts derived from the mechanisms
proposed to explain the observed improvements in walking
performance. These include improved nitric oxide bioavail-
ability and endothelial function,17 and skeletal muscle
metabolic adaptations to ischaemic conditions.17 Unfortu-
nately, such mechanisms are generally activated by the IRI
accompanying the claudication pain induced by treadmill-
based exercise in these patients. This may stimulate un-
wanted mechanisms such as a pro-inﬂammatory response
and catabolic state.
Similar to treadmill-based training, resistance training may
improve walking performance in patients with IC.11 Overall,
improvements in cardiovascular conditioning and a gain in
SMM leading to greater functional capacity are likely
responsible for this. A comparative group consisting of lower-
limb resistance training combined with treadmill-based
training was therefore chosen for this study as it was antic-
ipated that the additive effect of mechanisms responsible for
improvement in both treadmill and resistance training may
lead to greater improvements in walking performance.
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beneﬁcial effect on SMM and the calpain system.
Despite this, although a signiﬁcant improvement in
walking performance was observed within the treadmill-
only exercise group, this was not superior to the non-
signiﬁcant change observed in participants undertaking a
combination of treadmill and lower-limb resistance training.
While we were unable to demonstrate a superior effect of
the combined resistance training and treadmill training on
PFWD, it is expected that this is directly related to the
greater-than-expected variability in this outcome and
associated type 2 error rather than an ineffectual exercise
regimen. Variability in response to SET has been previously
demonstrated.18 Reasons for such variability are poorly
understood, but is likely multifactorial and determined by
the mechanism(s) of action underlying the potential bene-
ﬁcial effects of exercise in IC. Genetic factors are likely to be
involved in angiogenic or metabolic adaptations, while
psychological factors may contribute. Another factor that
may have contributed to the lack of observed improvement
in the combination-based exercise group is that in an
attempt to successfully combine two exercise modalities the
participants in the combination group were not exposed to
a sufﬁcient volume of either treadmill or resistance training
to enable an adaptive response to either modality to occur.
A similar conclusion was reached by Treat-Jacobsen et al.,18
who failed to demonstrate an additive effect of combining
arm-cranking and treadmill training. Consideration should
also be given to the fact that although participants were
asked to maintain their baseline level of physical activity, it
was not monitored and may be a confounding factor.
In contrast to walking performance, and suggesting a
beneﬁcial effect of the combination-based SET, are the re-
sults pertaining to SMM, which demonstrate a superiority
of a combination-based SET over a treadmill-based pro-
gramme. It seems that the impact of a SET on SMM in IC is
dependent on modality of exercise and may have a different
effect on symptomatic compared with asymptomatic legs.
Treadmill-only training resulted in a loss of SMM in symp-
tomatic legs that was signiﬁcantly different to the gain in
SMM observed in symptomatic legs after combination
training. These ﬁndings were also reﬂected in total body
SMM. In contrast, gains in SMM were observed in asymp-
tomatic legs, irrespective of exercise modality.
A mechanistic explanation for these changes in SMM may
lie with the calpain system. The proteolytic activity of the
calpain system is implicated in muscle apoptosis and
changes in muscle ﬁbre morphology.6 We know that SET in
claudicants results in changes in muscle ﬁbre types,17 and
an increase in calpain activity, as was observed with
treadmill-based SET, may be the intracellular mechanism
responsible for such change and, subsequently, the relative
loss of SMM observed in this group. The calcium-dependent
calpain system becomes activated when calcium levels are
physiologically increased by stimuli, such as IRI,6 and the
observed increase in calpain activity may be precipitated by
a greater exposure to IRI induced by repetitive bouts of
treadmill exercise.In the combination training group, lack of a signiﬁcant
effect on calpain activity is likely due to an interplay of
factors counteracting each other. Resistance training has
been shown to up-regulate expression of calpain and, to a
greater extent, its endogenous inhibitor calpastatin.19 While
not previously demonstrated, a potential decrease in cal-
pain proteolytic activity may ensue. Furthermore, the dis-
cussion above would suggest that exposure to a degree of
IRI induced by the treadmill-based component of the
combination-based SET is likely to increase calpain activity.
The net effect of such a programme is a non-signiﬁcant
decrease in calpain activity. In this way, other mechanisms
responsible for gains in SMM associated with resistance
training and the protective effect of aerobic training against
age-related reductions in SMM were allowed to proceed
without conﬂict from the calpain system and may explain
the beneﬁcial gain in SMM observed in this group of par-
ticipants. Support for this concept is also provided by the
signiﬁcant gain in SMM that was observed in the asymp-
tomatic legs of participants within both groups. Although
many of these limbs demonstrated radiological evidence of
atherosclerotic disease, it seems that the presence of clin-
ically signiﬁcant IRI manifesting as claudication pain and
potentially driving activation of the calpain system is the
most important precipitant of a loss of SMM arising from a
treadmill-based SET.
It has been demonstrated in an animal model that sepsis
stimulates calpain activity in skeletal muscle by decreasing
calpastatin activity.20 Our study did not observe any signif-
icant changes in calpastatin activity in either exercise group;
however, this may be a reﬂection of the high coefﬁcient of
variance that was recorded. Future work is required to
further evaluate the role of calpastatin in exercising
claudicants.
Whatever the mechanism underlying changes in SMM in
response to exercise in claudicants, the importance of
preserving SMM and the potential detrimental effect of a
relative loss of SMM in the treadmill-based training group
must not be understated. Whether this overrides the ex-
pected cardiovascular beneﬁts of exercise remains to be
seen and should be the subject of large-scale trials with
long-term follow-up; however, the central role played by
muscle in whole body protein metabolism is important in
response to physiological and pathological stress. Preser-
vation of SMM is an important contributor to functional
capacity and maintenance of quality of life, as well as
improving longevity in healthy individuals and those with
chronic disease.10
Although small and best described as a pilot study, this
work demonstrates that treadmill-based exercise as a
treatment for IC may be detrimental owing to the induction
of a catabolic muscle wasting state. The prescription of an
exercise programme to claudicants is focused on achieving
improvement in walking performance; however, this should
not come at the expense of physiological changes that are
likely to negatively impact on the health of a patient.
Findings from this study challenge whether treadmill-based
exercise training should remain the recommended
310 C.L. Delaney et al.treatment for patients with IC. On current evidence, the
lack of signiﬁcant improvement observed in walking per-
formance means that we are unable to recommend the
combination-based exercise regimen as a suitable alterna-
tive to treadmill training alone. Despite this, the superiority
of this regimen compared with the treadmill-based regimen
with respect to calpain activity and SMM would suggest
that, with appropriate modiﬁcations, it may have a role to
play in the future. Further large-scale work is required to
address the clinical need to look at better ways to design
exercise programmes for maximal beneﬁt rather than harm.
In planning such future work, consideration should also be
given to long follow-up periods to facilitate the assessment
of cardiovascular outcomes and ultimately determine
whether or not the changes observed in this current study
truly do manifest as detrimental to long-term health
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